Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin Add-on to Alpha Blocker in Men with Residual OAB Symptoms
NCT00699049Phase 4Completed
- Start
- Jun 2008
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in overactive bladder (OAB) comparing Alpha blocker + Solifenacin with Alpha blocker + Placebo (2 arms). Primary endpoint: Achievement level of patients' individual satisfaction at 12 weeks. Started Jun 2008; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00699049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699049.